Antianxiety effect of cannabidiol in the elevated plus-maze

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02244012PMID 1969666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects

  2004cited by this paper
• Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

  1986cited by this paper
• Cannabinoid pharmacology.

  1986cited by this paper
• Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

  1985cited by this paper
• Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

  1982cited by this paper
• Comparative effects between cannabidiol and diazepam on neophobia food intake and conflict behavior

  1981cited by this paper
• Chronic administration of cannabidiol to healthy volunteers and epileptic patients.

  1980cited by this paper
• Comparison of four vehicles for intraperitoneal administration of Δ1‐tetrahydrocannabinol *

  1971cited by this paper

• Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats

  2026cites this paper
• Repeated administration of cannabidiol decreases splenic lymphocyte subset numbers in rats

  2026cites this paper
• Chronic Cannabidiol Treatment Effects on Contextual Fear and Neuropathic Pain in Carioca Rats High and Low Conditioned Freezing.

  2025cites this paper
• Unravelling a potential therapeutic effect of polymeric lipid-core nanoencapsulated cannabidiol on anxiety- and panic-like behaviours elicited by Bothrops jararaca lancehead pit vipers.

  2025cites this paper
• Cannabidiol improves L-DOPA-induced dyskinesia and modulates neuroinflammation and the endocannabinoid, endovanilloid and nitrergic systems.

  2025cites this paper
• Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder

  2025cites this paper
• Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.

  2025cites this paper
• The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors

  2025cites this paper
• The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety

  2025cites this paper
• Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol

  2025cites this paper
• Repeated administration of cannabidiol decreases splenic lymphocyte numbers in rats: involvement of CB2 receptors

  2025cites this paper
• A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.

  2025cites this paper
• Canabidiol, ansiedade e memórias aversivas: uma revisão das evidências pré-clínicas

  2025cites this paper
• Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis

  2025cites this paper
• The Effects of Antioxidant Approved Drugs and Under Investigation Compounds with Potential of Improving Sleep Disorders and their Associated Comorbidities associated with Oxidative Stress and Inflammation.

  2025cites this paper
• Effect of Frequency of Prospekta Administration: Anxiolytic Effect in Wistar Rats

  2025cites this paper
• Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis

  2025cites this paper
• Stereoselective Synthesis of Cannabidiol and its Unnatural Enantiomer to Evaluate Anxiolytic‐Like Properties and Memory Interactions

  2025cites this paper
• Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy

  2025cites this paper
• Potentiation of endocannabinoid signaling alleviates depressive-like behavior in diabetic mice

  2025cites this paper
• Minor Cannabinoids CBD, CBG, CBN and CBC differentially modulate sensory neuron activation

  2025cites this paper
• Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model.

  2025cites this paper
• Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review

  2025cites this paper
• Sex Differences in the Anxiolytic Properties of Common Cannabis Terpenes, Linalool and β-Myrcene, in Mice

  2024cites this paper
• Cannabidiol in anxiety disorders: Current and future perspectives.

  2024cites this paper
• Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice.

  2024cites this paper
• The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials

  2024cites this paper
• Cannabidiol inhibits transient receptor potential canonical 4 and modulates excitability of pyramidal neurons in mPFC

  2024cites this paper
• Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders

  2024cites this paper
• Historical perspective on the therapeutic potential of cannabidiol.

  2024cites this paper
• Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats

  2024cites this paper
• The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial

  2024cites this paper
• Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic-pituitary-adrenal (HPA) axis responsivity in female and male mice

  2024cites this paper
• Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review

  2024cites this paper
• Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Therapeutic potential of CBD in Autism Spectrum Disorder.

  2024cites this paper
• Cannabidiol and brain function: current knowledge and future perspectives

  2024cites this paper
• Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models

  2024cites this paper
• Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission.

  2024cites this paper
• Cannabidiol Treatment Shows Therapeutic Efficacy in a Rodent Model of Social Transfer of Pain in Pair-Housed Male Mice

  2023cites this paper
• Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice.

  2023cites this paper
• Long-term Effects of Cannabidiol and/or Fentanyl Exposure in Rats Submitted to Neonatal Pain.

  2023cites this paper
• Developmental intervention with CBD on BDNF levels and Developmental intervention with CBD on BDNF levels and prosocial behavior in a mouse model of autism spectrum disorder prosocial behavior in a mouse model of autism spectrum disorder

  2023cites this paper
• Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder

  2023cites this paper
• Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer’s-like cognitive impairment in zebrafish and mice

  2023cites this paper
• Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice.

  2023cites this paper
• Roadmap For The Expression Of Canonical and Extended Endocannabinoid System Receptors and Proteins in Peripheral Organs of Preclinical Animal Models

  2023cites this paper
• Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model

  2023cites this paper
• Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.

  2023cites this paper
• Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis.

  2023cites this paper
• Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.

  2023cites this paper
• THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

  2023cites this paper
• Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556

  2023cites this paper
• The Estrous Cycle Influences the Effects of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibition in the Anxiety-Like Behavior in Rats

  2023cites this paper
• Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review

  2023cites this paper
• Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review

  2023cites this paper
• UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

  2023cites this paper
• Discriminative-stimulus effects of cannabidiol oil in Sprague-Dawley rats

  2023cites this paper
• Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry

  2023influential citation
• Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration

  2023cites this paper
• An Overview of Cannabidiol.

  2023cites this paper
• Cannabidiol (CBD) in Cancer Management

  2022cites this paper
• Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice.

  2022cites this paper
• Rutin Improves Anxiety and Reserpine-Induced Depression in Rats

  2022cites this paper
• Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures

  2022cites this paper
• Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors.

  2022cites this paper
• Autism and associated disorders: cannabis as a potential therapy.

  2022cites this paper
• Differentiation of industrial hemp strains by their cannabinoid and phenolic compounds using LC × LC-HRMS

  2022cites this paper
• Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool

  2022influential citation
• The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration

  2022influential citation
• Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder

  2022cites this paper
• The Reversal of Empathy-Induced Hypernociception in Male Mice by Intra-Amygdala Administration of Midazolam and Cannabidiol Depends on 5-HT3 Receptors

  2022cites this paper
• Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety

  2022cites this paper
• Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in mice.

  2022cites this paper
• Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic

  2022cites this paper
• Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze

  2022cites this paper
• CB1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers

  2022cites this paper
• Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.

  2022cites this paper
• Effects of cannabidiol on weight and fasting blood sugar with chronic and subchronic haloperidol administration

  2022cites this paper
• Cannabinoid Treatments for Anxiety: A Systematic Review and Consideration of the Impact of Sleep Disturbance.

  2022cites this paper
• Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives

  2022cites this paper
• Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions

  2022cites this paper
• Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

  2022cites this paper
• Medicinal Cannabis and Central Nervous System Disorders

  2022cites this paper
• Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone

  2022cites this paper
• Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via in vivo PET Imaging and Behavioral Assessment

  2022cites this paper
• Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

  2022cites this paper
• Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

  2022cites this paper
• Cannabis de grado médico para el tratamiento de la dependencia a Δ-9-Tetrahidrocannabinol

  2022cites this paper
• Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice

  2022cites this paper
• Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

  2021cites this paper
• Endocannabinoids, Cannabinoids and the Regulation of Anxiety.

  2021cites this paper
• Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations

  2021cites this paper
• Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?

  2021cites this paper
• Maternal and Fetal Pharmacokinetic Analysis of Cannabidiol during Pregnancy in Mice

  2021cites this paper
• The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.

  2021cites this paper
• Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.

  2021cites this paper
• Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice

  2021cites this paper
• Palmitoylethanolamide: A Potential Alternative to Cannabidiol

  2021cites this paper
• Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex

  2021cites this paper